Epirus Biopharmaceuticals Inc Stock Nasdaq
Equities
US29428P1075
Biotechnology & Medical Research
Financials (USD)
Sales 2014 | 0 | Sales 2015 | 0.7 | Capitalization | 75.33M |
---|---|---|---|---|---|
Net income 2014 | -41M | Net income 2015 | -52M | EV / Sales 2014 | 14,770,294,750 x |
Net cash position 2014 | 14.18M | Net cash position 2015 | 16.68M | EV / Sales 2015 | 83,658,631 x |
P/E ratio 2014 |
-0.83
x | P/E ratio 2015 |
-1.35
x | Employees | - |
Yield 2014 * |
-
| Yield 2015 |
-
| Free-Float | 100% |
1st Jan change | Capi. | |
---|---|---|
+22.10% | 47.07B | |
+46.45% | 42.06B | |
-3.12% | 39.98B | |
+36.10% | 33.02B | |
-6.30% | 27.9B | |
+18.71% | 27.63B | |
+46.15% | 14.37B | |
+44.52% | 13.45B | |
+0.19% | 12.03B |